Febe van Maldegem

13PUBLICATIONS
91CO-AUTHORS
Solid tumoursTumour immunologyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 01, 2026
Mechanisms of systemic immune modulation in tumor development: Interactions across lymph nodes, bone marrow, and blood.

|Sep 10, 2026
PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity.

|Jul 06, 2026
Statescope: an integrative deconvolution framework for discovering cell states in tumors.

|Jun 22, 2026
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial.

|Nov 28, 2025
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLC.

Ezgi B Ulas, Sofie J I Koomen, Anne Vrijmoet

|Nov 01, 2024
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses.

Megan Cole, Panayiotis Anastasiou, Claudia Lee

Pageof 3

Frequent Collaborators

6 joint publications

Julian Downward

4 joint publications

Katey S S Enfield

4 joint publications

Charles Swanton

4 joint publications

Emma Colliver